Clinical Trial Update: Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating intrathecal pemetrexed in combination with bevacizumab for leptomeningeal metastases in non-small cell lung cancer; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Avastin (bevacizumab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Lung Cancer (NSCLC), Leptomeningeal Metastasis | Phase 1 | Status: RECRUITING